--- title: "CME Group Amends Multi-Currency Secured Credit Facility" type: "News" locale: "en" url: "https://longbridge.com/en/news/284271645.md" description: "CME Group has amended its multi-currency revolving secured credit facility, maintaining a $7 billion capacity, expandable to $10 billion, effective April 22, 2026. This facility aims to provide liquidity during financial disruptions and is secured by clearing firm assets. Analysts rate CME stock as a Sell with a $273 price target, while AI Analyst Spark rates it as Outperform due to strong financial performance, despite weaker technical momentum. CME operates a major derivatives clearing house, focusing on market integrity and counterparty risk management." datetime: "2026-04-27T21:18:20.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/284271645.md) - [en](https://longbridge.com/en/news/284271645.md) - [zh-HK](https://longbridge.com/zh-HK/news/284271645.md) --- # CME Group Amends Multi-Currency Secured Credit Facility ### Claim 55% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks The latest update is out from CME Group ( (CME) ). Effective April 22, 2026, Chicago Mercantile Exchange Inc. amended its existing 364-day multi-currency revolving secured credit facility with a syndicate of banks led by Bank of America and Citibank, maintaining a $7 billion capacity that can be increased to $10 billion. The facility is designed to provide temporary liquidity in scenarios such as a clearing firm default, depositary liquidity issues, or domestic payment system disruptions, and is secured by clearing firm guaranty fund cash or U.S. Treasuries and performance bond assets, while requiring CME to meet a consolidated tangible net worth test, reinforcing the robustness of its clearinghouse risk and liquidity framework. The most recent analyst rating on (CME) stock is a Sell with a $273.00 price target. To see the full list of analyst forecasts on CME Group stock, see the CME Stock Forecast page. **Spark’s Take on CME Stock** According to Spark, TipRanks’ AI Analyst, CME is a Outperform. CME scores well primarily due to strong financial performance (durable revenue growth, exceptionally high margins, conservative leverage, and strong cash generation) and a very positive earnings update with record activity and clear product/technology milestones. The score is tempered by weaker near-term technical momentum (below key short-term moving averages with negative MACD), while valuation is supportive thanks to a solid dividend yield and a reasonable P/E. To see Spark’s full report on CME stock, click here. **More about CME Group** CME Group, through its subsidiary Chicago Mercantile Exchange Inc., operates a major derivatives clearing house that supports trading and risk management across multiple asset classes. The company provides clearing and settlement services for futures, options, and other derivatives, focusing on maintaining market integrity and managing counterparty risk for its clearing firms and market participants. **Average Trading Volume:** 2,380,359 **Technical Sentiment Signal:** Buy **Current Market Cap:** $103.4B For an in-depth examination of CME stock, go to TipRanks’ Overview page. ### Related Stocks - [CME.US](https://longbridge.com/en/quote/CME.US.md) - [BAC.US](https://longbridge.com/en/quote/BAC.US.md) - [C.US](https://longbridge.com/en/quote/C.US.md) - [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md) - [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md) - [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md) - [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md) - [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md) - [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md) - [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md) - [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md) - [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md) - [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md) - [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md) - [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md) - [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md) - [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md) - [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md) - [8648.JP](https://longbridge.com/en/quote/8648.JP.md) - [C-R.US](https://longbridge.com/en/quote/C-R.US.md) ## Related News & Research - [CME Group (CME) Valuation Check After Strong Q1 Earnings And New DTCC Cross Margining Approval](https://longbridge.com/en/news/284740394.md) - [KBW Keeps Their Hold Rating on CME Group (CME)](https://longbridge.com/en/news/283972351.md) - [CME Stock Under Pressure After Double Miss](https://longbridge.com/en/news/283673510.md) - [How Investors Are Reacting To CME Group (CME) Record Q1 Results And New Derivatives Expansion](https://longbridge.com/en/news/284138660.md) - [CME Group (CME) Q1 earnings report preview: What to look for](https://longbridge.com/en/news/283433427.md)